BRD2 and breast carcinoma: Previous studies have shown that LH/FSH signaling through LHR/FSHR activates G protein-coupled ROCK–moesin and FAK–paxillin axes, significantly enhancing invasive pseudopod formation and transendothelial migration in breast cancer cells [32,42].